CLOV vs MRVL · rev $1.37B vs P/E 100, rev $8.19B
Clover Health Investments Corp (CLOV) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
CLOV currently screens at market cap $1.55B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the CLOV and MRVL stock pages for the full models.
Not investment advice.